Trending Now
Vaxart Inc. (NASDAQ: VXRT) Announces Progress in the Development of Its...
Vaxart Inc. (NASDAQ: VXRT) has released its business update for Q3 2021, showing strong momentum in developing its oral vaccine platform that comprises tablet...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Senti Biosciences Inc (NASDAQ:SNTI) surges post CEO’s participation on Gene Regulation...
Stock of Senti Biosciences (NASDAQ:SNTI) last traded at $5.14 USD, a gain of +2.64 (105.60%). More than 68,212,695 shares exchanged hands compared to an...
MAKE IT MODERN
LATEST REVIEWS
Kala Pharmaceuticals Inc (NASDAQ: KALA) Recently Issued an Update on Its...
Kala Pharmaceuticals Inc ( NASDAQ: KALA) recently updated its shareholders on the latest decision made by UnitedHealth care to place EYSVIS as part of...
MAKE IT MODERN
PERFORMANCE TRAINING
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) Doses First Patient on Phase 2b MM-120 Study...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) has announced the dosing of the first patient in the Phase 2b dose-optimization study of MM-120 for Generalized...
Akebia Therapeutics Inc (NASDAQ:AKBA) Will Post Q1 2021 Revenues On May 10, 2021: NEJM...
Akebia Therapeutics Inc (NASDAQ:AKBA) will release Q1 2021 earnings on May 10, 2021. It will host a conference call on the same day at...
Tech Driven Rally Set to Squeeze Invesco QQQ higher (MNDY,LLY,AFRM)
The QQQ’s are slightly higher this morning as the semiconductors are mixed and trying to find a direction this morning after gapping...
Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Signs an Exclusive License and Supply Agreement Pact with...
Estimates have it that more than five million patients live on insulin and are at risk of severe hypoglycemia. The bad news is that...
Gritstone Bio Inc. (NASDAQ: GRTS) Announced Positive Clinical Results Of CORAL-BOOST Study Of samRNA...
Gritstone bio Inc. (NASDAQ: GRTS) has shared encouraging Phase 1 clinical findings from cohort 1 (10 µg dose of CORAL self-amplifying mRNA (samRNA) vaccine)...
MAKE IT MODERN
